RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Prognostic implications of DPP-4 inhibitor vs. sulfonylurea use on top of metformin in a real world setting - results of the 1 year follow-up of the prospective DiaRegis registry.

Prognostic implications of DPP-4 inhibitor vs. sulfonylurea use on top of metformin in a real world setting - results of the 1 year follow-up of the prospective DiaRegis registry.

Add to Collection
2013 Oct Others Fist_Author_Year_PM

Full Author : ['Gitt, A K', 'Bramlage, P', 'Binz, C', 'Krekler, M', 'Deeg, E', 'Tschope, D']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2013
Cited by : Not Available

BACKGROUND: DPP-4 inhibitors (DPP4-I) have been shown to provide non-inferior glycaemic control compared with sulfonylureas (SU), but result in a reduction of body weight and a significantly lower risk of hypoglycaemia in patients with type 2 diabetes. We.....

Keywords : ["real world set result", "inhibitor vs sulfonylurea use", "prospective diaregis registry", "year followup", "prognostic implication", "top", "metformin"]